In the current study, we aimed to correlate genetic data (density/length polymorphisms) with phenotypic data (CR1 density per erythrocyte (CR1/E) and soluble CR1 (sCR1)) in patients with AD and control subjects. The gene discussed is CR1; the disease is Alzheimer disease.